PMID: 9646331Jul 1, 1998Paper

Amlodipine dynamic effects and myocardial pharmacokinetics in the isolated and perfused guinea-pig heart

Pharmacology & Toxicology
P JeppesenF Nielsen-Kudsk

Abstract

Myocardial dynamic effects and pharmacokinetics of amlodipine were studied in the isolated retrogradely perfused and spontaneously beating guinea-pig heart. Pharmacokinetic analysis of drug accumulation showed one-compartment characteristics with an half-life of 76 min. Whereas disposition exhibited two-compartment characteristics with phasic half-lives of 25 and 174 min., respectively. Myocardial drug accumulation was increased by 600 times at steady-state compared to the perfusion liquid. Dynamic effect parameters were studied during increasing amlodipine concentrations from 0.16 to 220 nM. Dynamic steady-states developed within 20 min. Coronary flow-rate increased with an Emax of 119% and an EC50 of 1.2 x 10(-8) M. Amlodipine produced inhibitory effects on contraction amplitude and velocities of contraction and relaxation. Observed Emax-values and curve-fitted EC50-values were: 97, 97 and 94% and 1.10(-8), 7.7 x 10(-9) and 2.1 x 10(-8) M, respectively. Heart frequency was not changed. Oxygen consumption increased markedly to a maximum of 44% at 3 x 10(-8) M amlodipine and then decreased to nearly initial values. The frequency-corrected QT-interval decreased to a maximal extent of 20% at the three highest concentrations. Myoc...Continue Reading

References

May 1, 1992·Pharmacology & Toxicology·S MellemkjaerF Nielsen-Kudsk
Jul 8, 1991·Ugeskrift for laeger·O L Pedersen, P Schroeder
Nov 7, 1989·The American Journal of Cardiology·P T HoffB R Lucchesi
Nov 7, 1989·The American Journal of Cardiology·A FleckensteinG Fleckenstein-Grün
Nov 7, 1989·The American Journal of Cardiology·W G Nayler
Nov 7, 1989·The American Journal of Cardiology·R S KassS Chin
Mar 1, 1988·Pharmacology & Toxicology·H K Jensen, F Nielsen-Kudsk
Jul 1, 1986·Acta Pharmacologica Et Toxicologica·J Askholt, F Nielsen-Kudsk
Sep 1, 1981·Acta Physiologica Scandinavica·A Edlund, A Wennmalm
Sep 1, 1996·Cardiovascular Drugs and Therapy·R FerrariC Ceconi
Dec 1, 1996·Canadian Journal of Physiology and Pharmacology·Q TimourG Faucon

❮ Previous
Next ❯

Citations

Apr 20, 2019·The Journal of General Physiology·María Micaela López AlarcónAriel L Escobar
Oct 9, 2020·Human & Experimental Toxicology·Seong-Ho OkJu-Tae Sohn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.